The Biological Window in Alzheimer’s Disease: Real-World Lab Data for Commercial Execution
For real-world data (RWD) and commercial teams navigating the complex landscape of early-stage...
.png)
Precision Targeting in Rare Disease: Why Lab Data is the "Early Warning System" Pharma Needs
We are living in an era of unprecedented rare disease advocacy. Medical parents and patient groups...
Beyond the Centers of Excellence: Maximizing ROI and Finding the Missing Rare Disease Patient Cohort
The pursuit of patients with rare diseases is a critical but notoriously challenging endeavor for...
Case Study: Optimizing Patient Identification in Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndromes (MDS) are a group of bone marrow disorders characterized by ineffective...
Driving Commercial Strategy in ALL: The Critical Role of Lab Data
For pharmaceutical commercial teams, understanding the full patient journey is critical. In the...
Liquid Biopsies: A Game-Changer for Outreach to Healthcare Providers
In the fast-paced world of medicine, staying ahead of the curve is essential for pharmaceutical...
Lab Testing Trends Year-to-Date Through July 17
Prognos is analyzing lab testing trends in 2020 and more specifically, looking at the impact of...
Lab Testing Trends Year-to-Date Through July 10
Prognos is analyzing lab testing trends in 2020 and more specifically, looking at the impact of...
Lab Testing Trends Year-to-Date Through July 3
Prognos is analyzing lab testing trends in 2020 and more specifically, looking at the impact of...
Lab Testing Trends Year-to-Date Through June 26
Prognos is analyzing lab testing trends in 2020 and more specifically, looking at the impact of...